We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Mylan Pays $9M To Settle Paclitaxel Patent Suit

Law360 (July 6, 2004, 12:00 AM EDT) -- Mylan Laboratories has agreed to pay $9 million to Tapestry Pharmaceuticals Inc. and Australia-based Mayne Group Ltd's U.S. unit to settle a patent lawsuit over the cancer treatment paclitaxel.

Mylan, the...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.